ArticleFrontiers in oncology2024

Experience with luspatercept therapy in patients with transfusion-dependent low-risk myelodysplastic syndromes in real-world clinical practice: exploring the positive effect of combination with erythropoietin alfa.

Anna Jonasova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.